Early treatment of Favipiravir in COVID-19 patients without pneumonia: a multicentre, open-labelled, randomized control study (2022)
Attributed to:
New Branched Polymers Excipients and Emulsions for Enhanced Drug Delivery
funded by
EPSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1080/22221751.2022.2117092
PubMed Identifier: 35997325
Publication URI: http://europepmc.org/abstract/MED/35997325
Type: Journal Article/Review
Parent Publication: Emerging Microbes & Infections
Issue: 1
ISSN: 2222-1751